๐๏ธ Verified NIH Record โข Updated 2026-03-05
Precision Microbiota Interventions for Senoreduction Trial (NCT07462767)
Geroprotective Precision Medicine Strategies in PWH That Use Alcohol
๐ก Not Yet Recruiting Phase1 / Phase2 ๐ Clinical Research Protocol Sponsor: Louisiana State University Health Sciences Center in New Orleans
๐ฉบ Plain-English Summary (8th-Grade Level)
People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Who can join: Review the eligibility criteria below.
Location: LSU Health โ New Orleans, Louisiana
Age range: 40 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- LSU Health โ New Orleans, Louisiana
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in HIV Infections
- Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention โ Chicago, Illinois
- The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City โ New York, New York
- Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults โ Birmingham, Alabama
- Clinical Decision Support for PrEP โ Los Angeles, California
- Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care โ Baltimore, Maryland
- A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV โ Las Vegas, Nevada
Explore by condition: All HIV Infections clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.